News
Travis Perkins: Total Voting Rights
Travis Perkins: Total Voting Rights
DGAP-News: Adler Group S.A.: appeals against BaFin’s decision
DGAP-News: Adler Group S.A.: appeals against BaFin’s decision
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
DGAP-Adhoc: MAX Automation SE: Dusseldorf Regional Court grants application for court order to conduct a special audit and appoint a special auditor pursuant to Sec. 142 (2) AktG
DGAP-Adhoc: MAX Automation SE: Dusseldorf Regional Court grants application for court order to conduct a special audit and appoint a special auditor pursuant to Sec. 142 (2) AktG
PAO Severstal: Notice on Conference Call about Written Resolution issues for the Eurobond 2022
PAO Severstal: Notice on Conference Call about Written Resolution issues for the Eurobond 2022
Rights and Issues Investment Trust PLC: Share Buyback Programme Extension
Rights and Issues Investment Trust PLC: Share Buyback Programme Extension
Hardman & Co Research: The Fulham Shore (Initiation of coverage): Platform ready for take-off
Hardman & Co Research: The Fulham Shore (Initiation of coverage): Platform ready for take-off
Rights and Issues Investment Trust PLC: Appointment of Corporate Broker
Rights and Issues Investment Trust PLC: Appointment of Corporate Broker
SThree: Total Voting Rights
SThree: Total Voting Rights
Rights and Issues Investment Trust PLC: Half Year Report for the period to 30th June 2022
Rights and Issues Investment Trust PLC: Half Year Report for the period to 30th June 2022
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Total Voting Rights
Rights and Issues Investment Trust PLC: Total Voting Rights
Invitation Half-Year 2022 Results Media and Investor Conference Call and Webcast
Invitation Half-Year 2022 Results Media and Investor Conference Call and Webcast
Halfords Group PLC: Director/PDMR Shareholding
Halfords Group PLC: Director/PDMR Shareholding
Aroundtown SA: Release of a capital market information
Aroundtown SA: Release of a capital market information
DGAP-News: Medios AG: Contract of CEO Matthias Gaertner extended ahead of schedule
DGAP-News: Medios AG: Contract of CEO Matthias Gaertner extended ahead of schedule
KYOCERA Announces Consolidated Financial Results for Three Months Ended June 30, 2022
Kyocera Corporation (TOKYO:6971) today announced its consolidated financial results for the three months ended June 30, 2022 (the “first quarter,” or “FY23-Q1”), as summarized below. Complete
Ergomed (ERGO): Sustained growth momentum in H122
Ergomed (ERGO): Sustained growth momentum in H122
Bloc Ventures: Demand for deep tech unhindered by downturn
Bloc Ventures: Demand for deep tech unhindered by downturn
MD Medical Group Investments Plc: MD Medical Group announces operating results for Q2 2022
MD Medical Group Investments Plc: MD Medical Group announces operating results for Q2 2022
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
DGAP-News: UniDevice AG: Month Sales Record
DGAP-News: UniDevice AG: Month Sales Record
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Preclinical Evidence of Combination Therapy Potential for Varoglutamstat in AD at AAIC 2022
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Preclinical Evidence of Combination Therapy Potential for Varoglutamstat in AD at AAIC 2022
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Key Phase 2b Data at AAIC 2022 Showing that Varoglutamstat is Well Tolerated at Doses with High Target Inhibition, Highlighting Unique O
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Key Phase 2b Data at AAIC 2022 Showing that Varoglutamstat is Well Tolerated at Doses with High Target Inhibition, Highlighting Unique O
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements
DGAP-News: Dermapharm commits to acquire the French market leader for herbal medicinal products and food supplements